Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)

Details for Australian Patent Application No. 2005271767 (hide)

Owner Van Andel Research Institute

Inventors Vande Woude, George F.; Shinomiya, Nariyoshi; Zhang, Yu-Wen

Agent Griffith Hack

Pub. Number AU-B-2005271767

PCT Pub. Number WO2006/017322

Priority 60/587,044 13.07.04 US

Filing date 13 July 2005

Wipo publication date 16 February 2006

Acceptance publication date 16 September 2010

International Classifications

G01N 33/00 (2006.01) Investigating or analysing materials by specific methods not covered by groups

A01K 67/00 (2006.01) Rearing or breeding animals, not otherwise provided for

A01K 67/033 (2006.01) Rearing or breeding animals, not otherwise provided for

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017322 Priority application(s): WO2006/017322

16 September 2010 Application Accepted

  Published as AU-B-2005271767

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271779-Fiber tip detector apparatus and related methods

2005271763-Methods for treating cancer using agents that inhibit Wnt16 signaling